What is the long-term trend for Ameren's common stock, shares authorized under drplus plan (in shares)?

Over 2 years (2020 to 2022), Ameren's common stock, shares authorized under drplus plan (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from 4M to 4M.

Discontinued — last reported Q3 '23

Other

Common stock, shares authorized under DRPlus plan (in shares)

Ameren Common stock, shares authorized under DRPlus plan (in shares) remained flat by 0.0% to 3M in Q3 2023 compared to the prior quarter. Over 2 years (FY 2020 to FY 2022), Common stock, shares authorized under DRPlus plan (in shares) shows relatively stable performance with a 0.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementBalance Sheet Statement

SectionOther

CategoryCapital Allocation

SignalHigher is better

VolatilityStable

First reportedQ4 2018

Last reportedQ3 2023Nov 9, 2023

How to read this metric

A higher number indicates a robust program for shareholder participation in equity growth.

Detailed definition

The number of common shares reserved for issuance under the company's Dividend Reinvestment and Stock Purchase Plan (DRP...

Peer comparison

Standard for large-cap utilities with established dividend reinvestment programs.

Metric ID: other_common_stock_shares_authorized_under_dr_plus_plan

Historical Data

4 periods

	Q4 '21	Q4 '22	Q2 '23	Q3 '23
Value	4M	4M	3M	3M
QoQ Change	—	+0.0%	-25.0%	+0.0%
YoY Change	—	+0.0%	—	—

Range3M – 4M

Avg YoY Growth+0.0%

Median YoY Growth+0.0%

Common stock, shares authorized under DRPlus plan (in shares) at Other Companies

NiSourceNI View metric

Vulcan Materials CompanyVMC View metric

EquifaxEFX View metric

BlackstoneBX View metric

Corvex MOVE View metric

Keysight TechnologiesKEYS View metric

Frequently Asked Questions

What is Ameren's common stock, shares authorized under drplus plan (in shares)?: Ameren (AEE) reported common stock, shares authorized under drplus plan (in shares) of 3M in Q3 2023.
What is the long-term trend for Ameren's common stock, shares authorized under drplus plan (in shares)?: Over 2 years (2020 to 2022), Ameren's common stock, shares authorized under drplus plan (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from 4M to 4M.
What does common stock, shares authorized under drplus plan (in shares) mean?: The number of shares set aside for shareholders to reinvest their dividends into company stock.